Trading in financial markets involves significant risk of loss which can exceed deposits and may not be suitable for all investors.
Before trading, please ensure that you fully understand the risks involved
Trading in financial markets involves significant risk of loss which can exceed deposits and may not be suitable for all investors. Before trading, please ensure that you fully understand the risks involved
Investment Consultancy Research

The pharmaceutical sector comprises some of the largest companies in the world, including Pfizer (PFE), Merck & Co. (MRK), Bristol Myers Squibb (BMY), Johnson & Johnson (JNJ) and AbbVie (ABBV). You can trade more than 100 stocks and several pharma-focused ETFs with us.

The pharmaceutical industry raked in nearly $1.27 trillion in sales near 2020-end, significantly above the 2015 tally of $1.07 trillion, indicating a CAGR of 3.35%, per data compiled by Statista. The sector is focused on enhancing the quality of life.

This space is witnessing more clout and is in spotlight, more than ever before, as coronavirus pandemic has triggered alluring opportunities for pharma companies developing COVID-19 drugs and vaccines.

Why Trade Pharmaceutical
Stocks?

Strong Drug Pipeline: Pharma companies having robust drug pipelines are witnessed to address challenges arising from any decline in existing revenue streams led by expiring of patents and stiff competition. Notably, the leading pharmaceutical companies are known to consistently expand their revenue base and consequently, their earnings, most likely resulting in higher returns to the investor.
Innovation in New Drugs & Therapies: Pharmaceutical companies have several drugs in different stages of development. They publicly announce the development of a drug only when it qualifies to clinical testing stage in humans or await regulatory approval. Some clinical trials are involved with testing new drugs, meanwhile others test existing drugs intended for new uses. The top pharma companies are proficient with both development of new therapies and utilizing existing drugs aimed at new causes.
Huge Payoff for Effective Treatment: The average cost incurred in development of a new drug is significantly high. Also, the time taken between drug discovery and getting regulatory approval is 10 years on an average. Nevertheless, the payoff or the returns for delivering an effective treatment, particularly for a widespread ailment, can be enormous. Thereby, having the rights over an important patent can produce sizable profits for a pharma company for several years to come, with very little or almost no competition from fellow drugmakers.
Dividend Pay Outs: Several pharma companies are known to pay attractive dividends, making these stocks alluring picks for income-focused investors.
Aging Demography Bolsters Demand: The aging U.S. population is expected to propel the demand for pharma, making it more significant for years to come. As the boomer generation gets categorized as elderly, the requirement of prescription medications is touted to increase. This is expected to be capitalized largely by pharma companies, which bodes well for investors eyeing this space.

You Ask, We Answer

Whatever support you need, our service team is here to help. From account setup to platform help to analyzing markets, we’re here for you every step of the way. Call +971 (4) 356 2800 to speak with our global market specialist, visit our office in Downtown Dubai or chat with us online.

The Most Awarded Financial Service
Provider in the Region

The Most Awarded Financial Service Provider in the Region

Best Finance Education & Training UAE 2021
Best Research and Consultancy Firm, UAE, 2021
Best Investment Consultancy Firm, UAE, 2021
Best Investment support - Financial Investments, UAE, 2021
Most Customer Centric Investment Consultancy Firm 2021 Annual GBO Awards
Most Reliable Investment Solutions Provider UAE 2021 World Business Outlook

World’s #1 Platform

Next Generation is the multi-award winning trading platform with most advanced and user-friendly features and functionality. Built for traders, by traders, Next Generation platform offers varied award-winning features. Trade and manage positions directly from charts, access over 80 technical indicators and drawing tools, use automated pattern recognition.

platforms img-fluid
Customizable
dashboard
Notification
alerts
Advanced
charting
Client
sentiment
News &
research
Multi device
platform

Why Investors choose Century Financial

Trade in the Global Markets on the Next Generation trading platform designed by traders and supported by our impeccable service.

Pioneers in global financial markets: #1 in UAE

With over 3 decades of financial know-how, we help you meet the challenges of today’s global financial marketplace with -

  • Analysis
  • Research
  • Consultancy

Personalized Service

Ability to deliver an efficient investment approach to private, corporate and institutional customers.

Segregated Client Accounts

Clients’ money held with our principals’ regulated banks is maintained separately from their own accounts and held in segregated bank accounts as per the regulatory rules and policies of each principal. Your money and assets are ring-fenced from creditors in the unlikely event that any principal goes into liquidation.

Value for Money

We provide utmost value by way of dedicated support and services to each of our clients, irrespective of the size of their investment.

Execution Control

Enter and exit trades in a flash with our cutting-edge technology. There are multiple order types available, so you can control exactly when and how your trades are executed.

Over 3 decades of experience

Regulated by SCA

Dedicated Support 24 hours a day

Over 40,000 diversified instruments

Across 125 markets worldwide

40,000

Shares

100+

Indices

300

Commodities

90

Treasuries

2,000+

ETFs

330

Currencies

Trading in financial markets involves significant risk of loss which can exceed deposits and may not be suitable for all investors.
Before trading, please ensure that you fully understand the risks involved
Trading in financial markets involves significant risk of loss which can exceed deposits and may not be suitable for all investors. Before trading, please ensure that you fully understand the risks involved
*Disclaimer: Century Financial Consultancy LLC (“CFC”) is Limited Liability Company incorporated under the Laws of UAE and is duly licensed and regulated by the Emirates Securities and Commodities Authority of UAE (SCA). Services offered by CFC include promotion and introduction of financial market products that are traded on margin and can result in losses that exceed deposits. Trading with leverage carries a significant risk of losses and as such margin products may not be suitable for everyone; you should consider your investment objectives, risk tolerance, and your level of experience with these products, and ensure that you understand the risks involved and seek independent advice from professionals/experts if necessary. CFC is not responsible or liable for any result, gain or loss, based on this information, in whole or in part. Refer to risk disclosure on our website.

© 2022 CENTURY FINANCIAL CONSULTANCY LLC. ALL RIGHTS RESERVED.